TargetEpidermal growth factor receptor(Homo sapiens (Human))
Rutgers, The State University Of New Jersey
US Patent
Rutgers, The State University Of New Jersey
US Patent
Affinity DataIC50: >100nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Rutgers, The State University Of New Jersey
US Patent
Rutgers, The State University Of New Jersey
US Patent
Affinity DataIC50: >100nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Rutgers, The State University Of New Jersey
US Patent
Rutgers, The State University Of New Jersey
US Patent
Affinity DataIC50: >100nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Rutgers, The State University Of New Jersey
US Patent
Rutgers, The State University Of New Jersey
US Patent
Affinity DataIC50: >100nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Rutgers, The State University Of New Jersey
US Patent
Rutgers, The State University Of New Jersey
US Patent
Affinity DataIC50: >100nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Rutgers, The State University Of New Jersey
US Patent
Rutgers, The State University Of New Jersey
US Patent
Affinity DataIC50: >500nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Rutgers, The State University Of New Jersey
US Patent
Rutgers, The State University Of New Jersey
US Patent
Affinity DataIC50: >500nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Rutgers, The State University Of New Jersey
US Patent
Rutgers, The State University Of New Jersey
US Patent
Affinity DataIC50: >500nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Rutgers, The State University Of New Jersey
US Patent
Rutgers, The State University Of New Jersey
US Patent
Affinity DataIC50: >500nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Rutgers, The State University Of New Jersey
US Patent
Rutgers, The State University Of New Jersey
US Patent
Affinity DataIC50: >1.00E+3nMAssay Description:Briefly, the assay method measures ADP formed from EGFR kinase activity using luminescence derived from ATP-Luciferase detection system. Purified EGF...More data for this Ligand-Target Pair